We found a dose-dependent reduction in tissue loss at the thoracic injury site, with greater residual amounts of both gray matter and myelinated white matter. The maximum dose (15 nmol) significantly reduced the average length of the lesions and doubled the area of residual white matter at the epicenter. Serotonin immunoreactivity caudal to the lesion, used as a marker for descending motor control axons, was also increased in a dose-related manner and nearly tripled with the highest dose of NBQX as compared to controls. Most importantly, the reduced tissue loss in NBQX-treated groups was correlated with reduced functional deficits. There was a dose-dependent enhancement of speed and degree of recovery of both reflex and coordinated hindlimb motor activity, and reduction in the time required for establishing a reflex bladder. The long-term functional deficits at 4 weeks after SCI were reduced in a dose-related manner. Further, regression analyses demonstrated a significant correlation between the increase in amount of residual tissue and improvement in hindlimb function. Our results suggest that in this type of incomplete contusive SCI, a large and functionally important proportion of the tissue loss appears to be
The slow development of histopathological changes and lengthy period required for stabilization of the lesions (Allen, 19 14; Ducker et al., 197 1; Ballentine, 1978a,b; Bresnahan, 1978; Noble and Wrathall, 1989a) have long suggested that secondary injury processes exacerbate the effects of the initial mechanical insult after traumatic SCI. Strong evidence for the importance of secondary injury comes from the demonstration that various postinjury treatments can reduce neurological impairment resulting from a standardized experimental injury (e.g., Allen et al., 191 1; Hansebout et al., 1975; Faden et al., 1990) . One postinjury treatment, high doses of the steroid methylprednisolone, has now been found effective in large-scale clinical trials with human spinal cord injury patients (Bracken et al., 1990) . However, many physiological and biochemical alterations after SC1 have been described that may be involved in secondary injury processes (Blight, 199 1; Tator and Fehlings, 199 1; Hall, 1993; Young, 1993) . It has been difficult to isolate the contribution of individual factors and to estimate their importance in producing the overall long-term histopathological and functional consequences of SCI. The recent development of new pharmacological tools, drugs of high selectivity and potency, has provided the opportunity to examine experimentally the role of various mechanisms in secondary injury. To accomplish this purpose, it is necessary to obtain data from dose-response studies with highly specific compounds. The existence of post-traumatic local ischemia after SCI, coupled with evidence that excitatory amino acids (EAA) contribute to ischemic brain damage (Simon et al., 1984) , provided the rationale for initial studies on the effects of EAA antagonists on outcome after SC1 (Faden and Simon, 1988) . Selective antagonists of the NMDA-preferring subclass of EAA ionotropic receptors were shown to reduce the functional deficits produced by a standardized traumatic SC1 (Faden and Simon, 1988; Faden et al., 1988b Faden et al., , 1990 Gomez-Pinella et al., 1989) . Both systemic and intrathecal routes of administration were effective. However, in traumatic SC1 models, little (Gomez-Pinella et al., 1989) or no (Faden et al., 1988b) sparing of tissue at the lesion site was found, raising questions on the mechanism(s) through which functional deficits were reduced.
In additional studies on the role of EAA receptors in SCI, we found that kynurenic acid (KYNA), a nonspecific antagonist that inhibits both NMDA and non-NMDA ionotropic receptors (Birch et al., 1988; Danysz et al., 1989) , was effective in reducing the consequences of injury under conditions in which potent NMDA receptor antagonists were ineffective (Wrathall et al., 1992a) . We hypothesized that non-NMDA ionotropic receptors may be important in secondary injury. The first support for this hypothesis was obtained when we found that NBQX, a highly selective antagonist ofAMPA and kainate receptors (Sheardown et al., 1990) , administered beginning 5 min prior to SCI, significantly reduced the hindlimb deficits that result from a standardized injury (Wrathall et al., 1992b) . A single dose of NBQX was used, the maximum that could be administered under the conditions of the experiment, leaving open the question of the specificity of the observed effects.
We have now performed a dose-response study in which varying concentrations of NBQX were focally administered into the injury site beginning at 15 min after SCI. We determined the effects on functional deficits over time after SC1 and on quantitative histopathology, and serotonin immunoreactivity, at 4 weeks after injury. The resulting data were also used in regression analyses to examine the relationship between alterations in histopathology and functional impairment in NBQXtreated rats. The results demonstrate that NBQX reduces the functional defects resulting from SC1 in a dose-dependent manner and suggests that it does so by significantly reducing secondary loss of spinal cord tissue.
Material and Methods
Spinal cord injury. Female Sprague-Dawley rats (200-250 gm) were anesthetized with chloral hydrate (360 mg/kg, i.p.), and a laminectomy was performed at the T8 vertebral level to expose a 2.8-mm-diameter circle of dura. The animal was stabilized with angled Allis clamps on the T7 and T9 spinous processes, the impounder tip of a weight-drop device lowered onto the dura, and a 10 gm weight dropped 2.5 cm onto the impounder to produce a spinal cord contusion, as previously described . This model of contusive injury has been characterized in terms of biomechanics (Panjabi and Wrathall, 1988) functional deficits produced (Gale et al., 1985; Wrathall et al., 1985) , somatosensory evoked potentials (Raines et al., 1988) , effects on the blood-spinal cord barrier (Noble and Wrathall, 1989b) , and quantitative histopathology Wrathall, 1985, 1989a) .
After contusive injury, manual expression of bladders was performed twice daily until a reflex bladder was established, usually in the second week postoperatively. Postoperative care also included housing the rats in pairs to reduce isolation-induced stress, maintaining ambient temperature at 22-25°C and using highly absorbent bedding, as previously described , except that no prophylactic antibiotics were given. NBQX administration. NBQX (sodium salt), a highly selective antagonist of AMPA/kainate receptors (Sheardown et al., 1990) , was a gift of Novo Nordisk A/S (Malov, Denmark). NBQX was dissolved in deionized water (final pH 7.4) at a concentration of 3 mg/ml and diluted with vehicle as required. Vehicle (VEH) control animals received saline solution of similar osmolality and pH. Solutions were sterilized through 0.22 pm filters (Gelman Sciences, Ann Arbor, MI) and microinjected into the injury site beginning at 15 min after contusive injury. A total volume of 1.68 ~1 of solution was injected into the center of the injury site over a period of 8 min, through a sterotaxically placed 33 gauge needle, as previously described (Hoovler and Wrath& 199 1; Wrathall et al.. 1992b) . The dosaaes of NBOX used were 1.5. 5. and 15 nmol. the latter representing thi maximum that could be administered in this volume due to the limited solubility of the drug. The volume of solution and the slow injection paradigm were used to maximize the focal delivery to the injury site, based on preliminary dye injection experiments (Wrathall et al., 1992b) .
Experimental protocol. The experiment was performed according to a randomized block design. Experimental group sizes were chosen on the basis of power analyses of outcome measure data from injury doseresponse studies using this model of SC1 (Gale et al., 1985; Noble and Wrathall, 1985; Wrathall et al., 1985) . Based on these analyses, with 12 rats per group there is an 80% probability of detecting an effect equal to or greater than 34% in inclined plane score, 25% in the combined behavioral score, and 15% in white matter area at the epicenter (see below for description of these outcome measures). On each surgery day, four rats were subjected to contusive injury and randomly assigned to receive one of the three NBQX solutions (doses of 1.5, 5,. or 15 nmol) or the VEH alone. The arouns of NBOX-treated rats and VEH controls (n = 12 per group) were-behaviorally &ted at 1 d and weekly thereafter through 1 month after injury. They were then reanesthetized and spinal cord tissue fixed by perfusion for histopathological analyses, as described below.
Behavioral tests offunctional de&its. Tests of functional deficits were performed by individuals blind to the treatment groups. At each time point a battery of tests of hindlimb reflexes as well as coordinated use of hindlimbs were used, as previously described (Gale et al., 1985; Kerasidis et al., 1987) . The reflexes tested included toespread, placing, withdrawal in response to extension, pressure or brief pain, righting, and the reflex to lick the toes in response to heat. Coordinated motor activity assessed included open-field locomotion, swimming, and ability to maintain position on an incline plane. Results in individual tests
were examined separately and, in addition, overall hindlimb impairment was estimated with a combined behavioral score (CBS) that ranges from 0 in a normal rat to 100 in a rat with no evidence of hindlimb function. The CBS was develoned on the basis of initial iniurv dose-., , response experiments (Gale et-al., 1985) . It exhibits a normal distribution, as formally tested with the Wilk-Shapiro procedure (Shapiro and Wilk, 1965) , and was designed as a parametric statistic to provide a continuous measure of overall hindlimb deficits that is correlated to injury severity. It has greater statistical power than any of its component behavioral tests (Gale et al., 1985) and is significantly correlated with both degree of initial mechanical injury (Panjabi and Wrathall, 1988) and chronic histopathology Wrathall, 1985, 1989a) . Although not an actual percentage measure, within the context of this injury model the CBS is used to estimate the "percentage deficit" after SCI.
Histopathology. After the 4 week behavioral testing, animals were anesthetized with chloral hydrate and nerfused intracardiallv with saline followed by 4% paraformaldehyde in phosphate-buffered saline (pH 7.4). Spinal cord tissue was removed from the vertebral canal and a 1.5 cm segment centered on the injury site left in fixative for an additional hour, then equilibrated with increasing concentrations of sucrose solutions (1 O-20%) and frozen with dry ice-isopentane (-50°C). Ten spinal cords in each group were sectioned for morphometric and immunocytochemical analyses. The average CBS in each group was statistically indistinguishable from that of the relevant larger group (n = 12) for which behavioral data are reported. Serial 20 pm cross sections were cut with a Jung Frigicut 2800E cryostat, mounted with five sections (100 pm of tissue) per slide, on slides that were coated with 3-aminopropyltriethoxysilane (Koo et al., 1988) . All morphological analyses were done with tissue identified only by animal number; the evaluator was blind to the treatment group until after the primary data was collected.
For morphometry, every 10th slide was stained with 1~x01 blue/hematoxylin and eosin and projected, and areas ofgray matter, myelinated white matter, lesion cells (largely macrophages), and cavities were traced as previously described (Noble and Wrathall, 1985) . The tracings were digitized and areas of each tissue component calculated with a Zeiss IBAS image analysis system, through which three-dimensional reconstructions of the lesions were also generated.
For immunocytochemistry, rabbit antibody to serotonin (SHT) conjugated to bovine serum albumin (BSA) with paraformaldehyde was purchased from Incstar, Inc. (Minneapolis, MN, cat. #20080). -The antibody was purified with the aid of a BSA-aaarose (Sinma. St. Louis. MO, cat. #A-3790) column, to preclude nonspecific b&ding to BSA; and used at a dilution of 1:2000, as a marker for descending serotonergic innervation from the brainstem (Skagerberg and Bjorklund, 1985; Tork, 1990) . Spinal cord sections were selected that represented 5 mm caudal to the lesion epicenter. All of the selected sections were processed for immunocytochemistry together, along with sections through the thoracic cord of uninjured controls, using the same solutions to allow comparison of the relative staining for 5HT. Using a Zeiss IBAS image analysis system, fields of view containing the left or right (1) superficial laminae of the dorsal horn, (2) intermediolateral horn, (3) ventral horn, and (4) arately to determine the total areas (pixels) of stained immunoreactive terminals, using the same processing parameters for all samples. The data were combined to estimate total immunoreactivity &m2) for each area and for each spinal cord cross section. Statistical analyses. As both CBS and inclined plane data represent parametric data and were repeatedly measured after injury, the effects of treatments were compared statistically using repeated-measures ANOVA, followed by Tukey's test for differences at individual time points. The appropriateness of the model, initially recommended by Dr. D. Mundt, Division of Biostatistics and Epidemiology, Georgetown University, and used in previous studies (Wrathall et al., 1992a,b) , was tested with each individual set of data using the SAS statistical software. Nonparametric data (i.e., motor scores) were compared with the Wilcoxon test, as well as Bartholomew's test for trend of proportions. For comparison of areas of spared tissue at different levels of the spinal cord rostra1 and caudal to the epicenter, and 5HT-immunoreactive terminal areas caudal to the SC1 in treated and VEH control groups, one-way ANOVA was used. For linear regression analyses, Pearson's correlation coefficient was calculated for parametric data and Spearman's coefficient for nonparametric data. In all cases, confidence limits were set at 95%. Use of the term "significant" in the text indicates that statistical testing was performed and p < 0.05. (0) nmol of NBQX. Data were analyzed with repeated-measures ANOVA, which showed an overall significant (P i 0.05) effect of treatment. Asterisks indicate that means are significantly different from the vehicle-treated control group at the specified times after SC1 (Tukey's procedure).
Results
Effects of NBQX on functional dejicits after SCI As described previously in this model (Gale et al., 1985; Noble and Wrathall, 1989a) , rats at 1 d after SC1 demonstrated profound impairment of hindlimb function, including areflexia and inability to use their hindlimbs in coordinated motor functions such as locomotion.
Over the next several weeks partial recovery of function was seen until a plateau was reached at 3-4 weeks representing the long-term, chronic deficits associated with this degree of SCI. Focal infusion of NBQX produced a dose-related effect in increasing the speed and extent of recovery of hindlimb reflexes after SCI, such as pressure withdrawal ( Fig. 1 ) and others (data not shown). Recovery of coordinated motor function expressed in swimming ( Fig. 2 ) and maintaining'position on an inclined plane (Fig. 3) was enhanced. Recovery of locomotor function was also more rapid and occurred to a greater degree (Fig. 4) , with both effects exhibiting dose dependence. Overall hindlimb functional deficits, as estimated by the Combined Behavioral Score (CBS), were reduced in a dose-related manner, with both the 15 and 5 nmol groups demonstrating significantly better scores than VEH controls beginning 1 week after SC1 and throughout the course of the experiment (Fig. 5 ). After SCI, the normal control of micturation is lost and rats require manual expression of the bladder until a so-called reflex bladder is established, usually in the second week after SC1 . In addition to the effects on hindlimb function, NBQX administration was associated with a significant and dose-related reduction in the time required to develop a reflex bladder (Fig. 6 ). All rats survived the full 4 week course of the experiment without evidence of any deleterious effects of treatment and no effect on weight gain after injury (data not shown).
Eflects of NBQX on the histopathological lesion produced by SCI received the highest dose of NBQX. As reported previously in this model Wrathall, 1985, 1989a) , the lesioned area of the cord exhibited an elongated ovoid form with maximal tissue loss, the lesion epicenter, at the site of the initial impact. Rostra1 and caudal to the epicenter the lesion tapered, with its most distal elements in the ventral portion of the dorsal funicular white matter. At the epicenter, the cross-sectional profile of the spinal cord was reduced compared to the normal thoracic cord, or cross sections of the injured cord rostra1 or caudal to the epicenter. The epicenters were characterized by a peripheral, . Effect of NBQX on overall hindlimb deficits over time after injury. Deficits are expressed as a combined behavioral score (CBS) that ranges from 0 in normal rats to 100 in rats with abnormal function in all of the tests. Data points represent the average of 12 rats per group where groups received vehicle alone (0) or 1.5 (A), 5.0 0, or 15 (0) nmol of NBQX. Where no error bar is shown the SEM was smaller than the symbol. Data were analyzed with repeated-measures ANOVA, which showed an overall significant (P < 0.05) effect of treatment. Asterisks indicate that means are significantly different from the vehicletreated control group at the specified times after SC1 (Tukey's procedure). O-5 scale (the motor score, described in Wrathall et al., 1985) in which a grade of 3 or better indicates the ability to bear weight and use the hindlimbs for effective locomotion. Data points are individual scores for rats that received vehicle alone (0) or 1.5 (A), 5.0 (a, or 15 (0) nmol of NBQX; bars represent the modal score for the group. A significant (P < 0.05) treatment effect was present at each time point (Wilcoxon test) . The extent of recovery as measured by the motor scores was significantly higher in the 5 nmol group than controls at 7 and 14 d, and for the 15 nmol group, scores were significantly higher at 7, 14,2 1, and 28 d postinjury. The speed of recovery of locomotion also demonstrated a significant doserelated effect as indicated by the proportion recovering locomotor ability (motor score of 3 or higher) at 7 and 14 dafter SC1 (Bartholomew's test for trend of proportions).
often incomplete, rim of residual white matter, with the occasional presence of the most peripheral elements of gray matter. This residual spinal cord tissue surrounded the central lesion, consisting of cavities and a loose network of non-neuronal cells, mainly macrophages. Compared to VEH controls, in the group treated with 15 nmol of NBQX there appeared to be more residual spinal cord tissue, mostly white matter, at the lesion epicenter (Fig. 7AJ) . The cross-sectional profile frequently appeared larger and closer to the normal diameter of the spinal cord. Examination of sections rostra1 and caudal to the epicenter suggested that the length of the lesion was also less, especially in the group treated with 15 nmol of NBQX (Fig. 7C) .
These postulates were examined further using morphometric techniques. Determinations of gray matter area in sections of the epicenter and at specified distances rostra1 and caudal to it demonstrated a dose-dependent increase in residual gray matter cavities and a loose network of lesion cells (mostly macrophages), as previously described Wrathall, 1985, 1989a) , that are not distinguished in these tracings. C, Sections rostra1 and caudal to the epicenters from rats representative of those treated with vehicle alone (VEH) and those that received 15 nmol of NBQX suggest a reduced rostrocaudal extent of the lesion (cross hatched) in the latter group. Scale bar, 1 mm.
in sections adjacent to the epicenter (Fig. G&C) . In sections at 2 mm rostra1 to the epicenter, the group that received 15 nmol of NBQX averaged three times the area of residual gray matter; the 5 nmol group, twice as much. Staining of adjacent sections with Nissl stains confirmed the presence of healthy-appearing neurons in this spared gray matter (data not shown). Although there was statistically significant sparing of gray matter at the epicenter in the group treated with 15 nmol of NBQX, it was because of a complete absence of residual gray matter in VEH controls (Fig. 8C) . A quantitatively much greater effect of NBQX was seen at 2-4 mm rostra1 or caudal to the epicenter, with a maximal effect at about 2 mm. Similar analyses of area of myelinated white matter indicated a dose-dependent increase at the epicenter as well as in sections rostra1 and caudal to it (Fig. 8B) . In the group treated with the highest dose of NBQX (15 nmol), the average area of white matter at the epicenter was about double that in the VEH control group (Fig. 80) . The effect of NBQX in increasing residual white matter appeared quantitatively similar at the epicenter and in sections 1, 2, 3, or 4 mm rostra1 or caudal to it. Calculation of lesion lengths also showed a significant effect of NBQX (data not shown), with the group treated with the highest dose demonstrating a nearly 33% decrease in the length of the lesion. However, with respect to the average length of the lesion, the vehicle control and 1.5 nmol groups were statistically similar, as were the 5 and 15 nmol groups.
Antisera to serotonin (5HT) revealed reduced immunoreactivity caudal to the SC1 as compared to that in normal spinal cords (data not shown). Quantitative analyses of immunoreactive terminals in sections 5 mm caudal to the epicenter at 1 month after SC1 showed a dose-dependent effect of NBQX on overall terminal area, as well as 5HT terminals specifically in the dorsal horns, intermediolateral cell columns, in lamina X near the central canal, as well as in the ventral horns (Fig. 9) . In the group treated with the maximal dose of NBQX, the total 5HT terminal area averaged more than twice that in the VEH control group.
Correlation between tissue sparing and reduced functional dejicits produced by NBQX Linear regression analyses indicated significant correlations between sparing of tissue and reduction of functional deficits at 1 month after SCI. Degree of preservation of gray matter, white matter, and 5HT innervation below the injury site were each correlated to hindlimb locomotor function, as assessed by the motor score (Table 1) . Further, the preservation of gray and white matter throughout the lesioned segments of the spinal cord, the area of myelinated white matter at the lesion epicenter, and the area of SHT-immunoreactive terminals 5 mm caudal to the epicenter were significantly and strongly correlated to improvements in overall hindlimb function as estimated by the CBS (Table 1 ). the VEH control group (P < 0.05) when data were analyzed with one-way ANOVA. The significant differences in gray matter at the epicenter and I mm rostra1 level are due to its complete absence in the VEH group. Linear regression analyses were performed using the method of least squares to calculate Pearson's correlation coefficient (r) for the parametric CBS data, and Spearman's rank order correlation to calculate r, for the nonparametric motor score (MS) data. Injury site white matter (WM) and gray matter (GM) values were calculated as the sum of areas measured in individual cross sections of spinal cord at 2 mm intervals from 4 mm rostra1 to 4 mm caudal to the epicenter. Analyses were based on 29 rats for 5HT data (7-8 per experimental group), and 38 rats (9-10 per group) for the WM and GM data. overall deleterious effects of traumatic injury. Further, the effectiveness of focally applied NBQX, introduced into the injury site after SC1 by stereotaxic microinjection, indicates that the relevant receptors are located on cells at or very near the injury site. The study utilized a standardized model of contusive spinal cord injury in the rat that has been well characterized in terms of biomechanics (Panjabi and Wrathall, 1988) as well as behavioral (Gale et al., 1985; Wrathall et al., 1985; Kerasidis et al., 1987) neurophysiological (Raines et al., 1988) and histopathological Wrathall, 1985, 1989a) outcome measures. The anesthetic used, chloral hydrate, is thought to be particularly useful in studies on CNS function (Waynforth and Flecknell, 1992) , and at the dosage used (360 mg/kg, i.p.) produces a suitable level of anesthesia for surgery in Sprague-Dawley rats. We believe that the safety of this anesthetic, along with the absence of additional invasive procedures (e.g., arterial catheterization for physiological monitoring), contributed to the 100% survival rate for rats in this study. Further, chloral hydrate has no known direct effects on glutamate receptors.
Considerable evidence supports the hypothesis that the effects we observed are due to interaction of NBQX with local EAA receptors at or near the injury site. The microinjection paradigm used delivered a small volume of drug solution (1.68 ~1) over a relatively long period of time (8 min) to largely restrict the infusion to the injury site, as determined by preliminary dyeinjection experiments (Wrathall et al., 1992b) . Under these conditions, systemic effects on cardiorespiratory function or body temperature would be unlikely. However, in addition, body temperature was maintained both during surgery and postoperatively. It is therefore unlikely that the beneficial effects of NBQX that we observed were mediated through induction of hypothermia, as has been reported for MK-801 systemically administered to gerbils in an ischemic brain injury model (Buchan and Pulsinelli, 1990) . However, only measurements of temperature within the spinal cord at the injury site could rule out the possibility of a local temperature effect by NBQX. In a separate experiment, we have monitored various physiological parameters (e.g., blood pressure, respiratory rate, blood gases, etc.) after NBQX was microinjected into the spinal cords of normal or SC1 rats and found no significant alterations compared to VEH controls (Y. D. Teng and J. R. Wrathall, unpublished observations). Further, previous experiments using other antagonists of ionotropic receptors have also yielded evidence consistent with a role of local EAA receptors in contributing to the consequences of SC1 (Faden et al., 1990; Wrathall et al., 1992a) .
Several laboratories have shown that selective antagonists of the NMDA-preferring subclass of ionotropic receptors significantly reduce some of the consequences of experimental SCI. Faden and Simon (1988) initially found that dizocilpine (MK-80 l), a noncompetitive NMDA antagonist, administered intravenously at 1 mg/kg, 15 min after a moderate SCI, significantly reduced hindlimb functional impairments (locomotion, inclined plane) at 4 weeks after injury. Further studies confirmed the beneficial effects on locomotion and inclined plane score, and demonstrated a limited dose dependence of the effect on the former but not the latter (Faden et al., 1988b) . The behavioral effects were not associated with significant tissue sparing at the epicenter, but 5HT immunoreactivity in the lumbar spinal cord was significantly higher in the treated group in one experiment. Using a model of SC1 similar to that we used in this study, Gomez-Pinella et al. (1989) demonstrated a significant sparing of neurons in gray matter adjacent to the lesion in rats treated with MK-801. Administration was initiated 1 hr prior to SC1 (0.3 mg/kg, i.p.) and continued at 6-8 hr after SC1 with a subcutaneous infusion of 4.3 &kg/hr for 14 d. The neuroprotective effect was associated with improved function in some behavioral tests (locomotion, toespread reflex) but not others (inclined plane, withdrawal reflexes), and there was no significant effect on lesion length or volume.
The site of action of sytemically administered drugs is difficult to determine. Evidence for a role of local NMDA receptors in secondary injury was obtained by demonstrating the effectiveness of intrathecal administration of NMDA antagonists to the spinal cord near the injury site (Faden et al., 1990) . Both the noncompetitive antagonist dextrophan and the competitive antagonist 3-(2-carboxypiperazin-4-yl)propyl-1 -phosphonic acid (CPP) significantly improved locomotion at 4 weeks after SCI, with CPP also demonstrating a dose-dependent (100 mg better than 10 mg) effect on locomotion and 5HT levels caudal to the injury as well as a significant effect of the higher dose on inclined plane scores.
Evidence for the role of non-NMDA ionotropic receptors in SC1 began to accumulate with a comparative study (Wrathall et al., 1992a) of the effects of intravenous MK-801, dextromethorphan, and kynurenic acid, a nonspecific antagonist of EAA receptors that can block both NMDA and non-NMDA receptors (Birch et al., 1988; Danysz et al., 1989) . Under conditions in which the NMDA receptor antagonists were ineffective, we found that kynurenic acid significantly reduced functional deficits after SCI. It was also effective when administered intrathecally to the spinal cord or by direct microinjection into the injury site. With the later route of administration a significant dose-related effect was demonstrated, with significant improvement in a number of behavioral tests of hindlimb functional deficits. These results led to the hypothesis that non-NMDA ionotropic receptors may be important in secondary injury after spinal cord trauma (Wrathall et al., 1992a) .
Initial support for this hypothesis came from studies in which we found that a 15 nmol dose of NBQX microinjected into the injury site according to a split-dose protocol, in which half was administered 5 min prior to and the rest at 15 min after injury, significantly ameliorated the effects of injury on hindlimb function (Wrathall et al., 1992b) . The results of the current study provide additional strong support for the hypothesis by demonstrating a dose-dependent reduction in both tissue loss and functional impairment when this highly selective antagonist of AMPA/kainate receptors (Sheardown et al., 1990 ) is administered after SCI.
AMPA receptors have been identified by electrophysiological studies of spinal cord neurons in vivo and in vitro (Davies and Watkins, 1983; Nelson et al., 1986; Headley and Grillner, 1990; Arencio et al., 199 1; Salt and Herrling, 199 1) . These receptors are especially associated with monosynaptic responses to cutaneous myelinated afferents by neurons in both the dorsal and ventral horn. In addition, in the rat spinal cord, kainate receptors have been associated with neurons involved in the response to C-fiber afferents (Evans et al., 1987) . However, in general, mammalian spinal neurons display a mixture of NMDA and non-NMDA receptor types.
The role of different types of receptors in EAA-mediated neurotoxicity has been under intensive investigation using tissue culture preparations of various types of neurons (Choi, 1992; Rothman, 1992) . In cultures of cortical neurons, NMDA-preferring ionotropic receptors appear primarily responsible for rapidly triggered glutamate-induced cell death, but blockage of non-NMDA ionotropic receptors is also required to permit survival of neurons subjected to hypoxia and glucose deprivation for a prolonged period of time. Thus, NMDA receptors are postulated to be responsible for rapidly triggered excitotoxicity that is mediated by a rapid influx of Ca*+, and AMPA/kainate receptors for slowly triggered excitotoxicity in which the rate of Ca*+ influx is slower, and may involve routes other than receptor-gated channels (Choi, 1992) . In either case, the increase in intracellular Ca2+ is believed to initiate destructive cascades of events (e.g., Ca*+-activated proteases) that lead to neuronal death. Our results indicate the importance of non-NMDA receptormediated neurotoxicity after SCI, perhaps that associated with the hypoxia and hypoglycemia engendered locally by the traumatic compromise of the blood supply (Tator and Fehlings, 1991) .
The significant sparing of gray matter in rats treated with NBQX that we observed is consistent with reports of neuroprotection by NBQX against ischemic injury of cerebellar Purkinje cells (Balchen and Diemer, 1992) hippocampal CA1 neurons and cerebral infarction induced by focal ischemia (Sheardown et al., 1990; Buchan et al., 199 1 b,c; Gill et al., 1992) or transient global ischemia (LePeillet et al., 1992; Nellgaard and Weiloch, 1992) . However, ours appears to be the first report of NBQX-mediated neuroprotection after spinal cord trauma. Reduced neurotoxicity could in turn reduce other consequences of SCI, including edema, formation of oxygen-free radicals, and other molecules active in lipid peroxidation reactions (Hall, 1993) , that may indirectly exacerbate the effects of the initial trauma on white matter.
NBQX may also act at astrocytic glutamate receptors to modify their response to injury. Although neurons responsive to glutamate typically possess a variety of receptors, astrocytic glutamate receptors appear restricted to non-NMDA types (Usowicz et al., 1990 ). In addition, recent studies on glutamate receptors in white matter, as represented by the optic nerve, suggest that a small population of 02A glial precursors exist in adult white matter, and that they also appear to have functional non-NMDA ionotropic receptors (Fulton et al., 1992; Jensen and Chiu, 1993) . Thus, the effects of focally applied NBQX on spinal cord injury may be mediated through receptors on both neurons and glia and/or glial precursor cells.
Little is known about the role of glial receptors in traumatic injury. For example, astrocyte cultures are resistant to levels of glutamate that are toxic to neurons (Chan et al., 1990) . Oligodendrocyte cultures are sensitive to glutamate toxicity, but are not protected by the presence of either NMDA or non-NMDA receptor antagonists (Oka et al., 1993) although NBQX has not yet been tested. However, the presence of glia in neuronal cultures modifies and reduces the extent of neurotoxicity mediated by glutamate (Rosenberg and Aizenman, 1989) . Further, activation of glial glutamate receptors sets up a wave of elevation of intracellular free Ca2+ (Cornell-Bell et al., 1990 ) indicating a potential signaling mechanism through astrocytic networks. Such mechanisms could be involved in indirect effects of NBQX on white matter and serotonergic fibers, as well as neuroprotection. Our speculative hypothesis is that the capacity ofNBQX to act at glial as well as neuronal receptors could be the basis of its powerful effect in reducing both gray and white matter loss after SCI.
It is likely that the reduction in tissue loss after SC1 in rats treated with NBQX is causally related to the reduction of functional deficits resulting from the standardized traumatic injury. In previous experiments with this model in which we varied the degree of impact on the spinal cord, we found that the intensity of impact, tissue loss, and degree of functional impairment were significantly correlated to one another Wrathall, 1985, 1989a; Panjabi and Wrathall, 1988) . We had not assessed 5HT in these studies, but other investigators, using a rat model of SC1 similar to ours, have reported that loss of 5HT immunoreactivity caudal to the lesion was correlated to severity of experimental injury (Faden et al., 1988a) . In the present study, we kept the degree of impact injury constant but both the tissue loss and functional consequences were significantly varied due to treatment with NBQX. The significant correlations between the measures of tissue sparing at the injury site, and apparent sparing of 5HT terminals caudal to the injury, with behavioral indicators of hindlimb function (motor score, CBS) are consistent with, although they do not prove, a causal relationship. There are alternative possibilities. For example, increased 5HT caudal to the lesion could be due to an effect of NBQX leading to enhanced sprouting of spared fibers rather than increased sparing of the fibers passing through the injury site. In either case, the significant correlation between functional improvement and increased 5HT immunoreactivity is considered particularly important because these terminals represent an important descending motor control pathway from the brainstem (Tork, 1990) .
The effectiveness of NBQX in reducing the consequences of SC1 has potential clinical ramifications. Although the present study was limited to focally administered NBQX, additional experiments indicate that a more clinically relevant systemic administration can also significantly reduce deficits after SC1 (Wrathall, unpublished observations) . Determining its relative effectiveness for SCI, compared to selective NMDA antagonists (Faden and Simon, 1988; Faden et al., 1988b Faden et al., , 1990 GomezPinella, 1989; Wrathall et al., 1992a) or nonspecific antagonists such as kynurenic acid (Wrathall et al., 1992a) , will require further studies. Differences in the relative effectiveness of antagonists of different classes of glutamate receptors in vivo remain to be explained. Nevertheless, varying sensitivity to antagonists of NMDA and non-NMDA ionotropic receptors has been reported with different types of CNS injury. For example, selective NMDA antagonists appear to be powerful neuroprotectants after focal cerebral ischemia (e.g., Park et al., 1988) , but can be ineffective in transient global ischemic injury (Buchan et al., 1991a) . In the latter case, non-NMDA antagonists are protective (Buchan et al., 199 1 b; Nellgaard and Wieloch, 1992) . In SCI, there is now evidence of beneficial effects with either NMDA or non-NMDA receptor antagonists. It will be of considerable interest to determine whether a combination of both types of antagonists would be more effective than either alone, as has been reported for retinal ischemic injury (Mosinger et al., 199 1) and neurons in vitro (Kakau et al., 199 1) . Thus, in addition to providing a tool to investigate mechanisms of secondary injury after spinal cord trauma, NBQX, or similar drugs, may offer additional therapeutic approaches to SCI.
